Accelrys Technology to Enable Chemical Depiction in GenSys Software's Electronic Laboratory Notebook.SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. -- Accelrys, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ACCL ACCL American Canadian Caribbean Line ACCL Acceleration ACCL American College of Construction Lawyers ACCL Accreditation Council for Clinical Lipidology (Allied Health Certification Program) ACCL Amway China Co Limited ) today announced that its Accord(TM) Chemistry Control cheminformatics component will be used to enable chemical depiction in GenSys Software's Electronic Laboratory Notebook (GenSys/ELN(TM)). Under the terms of the agreement, GenSys will embed the Accelrys Accord Chemistry Control into its ELN Noun 1. ELN - a Marxist terrorist group formed in 1963 by Colombian intellectuals who were inspired by the Cuban Revolution; responsible for a campaign of mass kidnappings and resistance to the government's efforts to stop the drug trade; "ELN kidnappers target software, enhancing the electronic notebook with high-quality depiction of chemical structures. The GenSys/ELN lets researchers maximize productivity by moving beyond the limitations of paper-based notebooks through the ability to create, review, organize, share, discuss and archive laboratory records and associated data. Researchers can also forward entries to be witnessed and signed electronically using embedded digital signatures. "GenSys Software is committed to integrating our enterprise research platform with all of the best scientific software technologies available to the market," said Thomas Williams Thomas Williams may refer to:
"Accelrys strives to offer solutions to the market's needs and partnering with companies of GenSys' caliber lets us do so more efficiently," said Mahesh Krishnamurthy, Accelrys' senior vice president of corporate development. "Our Accord components provide chemical perception capabilities that can be readily integrated into professional software applications, such as ELNs, or even systems powering laboratory instruments," he added. About Accelrys, Inc. Accelrys, Inc. (NASDAQ:ACCL) is a world-leading scientific software company that develops and delivers innovative software applications, components, and services that help solve critical R&D problems. Accelrys' simulation and informatics software spans genetics, biology, chemistry, and materials science materials science Study of the properties of solid materials and how those properties are determined by the material's composition and structure, both macroscopic and microscopic. . These solutions enhance scientific insight and promote data management, thereby accelerating the discovery and development of pharmaceuticals, chemicals, and materials. For more information, visit www.accelrys.com. About GenSys Software, Inc. GenSys Software, Inc. is a leading global provider of innovative enterprise software solutions recognized for excellence in quality and support by life sciences, chemical and research-intensive organizations. GenSys provides the industry's most robust and secure enterprise Electronic Laboratory Notebook (GenSys/ELN(TM)) to meet customer research, legal, regulatory and information management needs and streamline R&D life cycles. Headquartered in Santa Monica Santa Monica (săn`tə mŏn`ĭkə), city (1990 pop. 86,905), Los Angeles co., S Calif., on Santa Monica Bay; inc. 1886. Tourism and retailing are important, and the city has motion-picture, biotechnology, and software industries. , Calif., GenSys is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. . For more information about GenSys products, services, and worldwide partners, visit: www.gensys.com. When used anywhere in this document, the words expects, believes, anticipates, estimates, and similar expressions are intended to identify forward-looking statements. Forward-looking statements herein may include statements addressing future financial and operating results of Accelrys. Accelrys has based these forward-looking statements on its current expectations about future events. Such statements are subject to risks and uncertainties including, but not limited to, the successful implementation of Accelrys' strategic plans, the acceptance of new products, the obsolescence ob·so·les·cent adj. 1. Being in the process of passing out of use or usefulness; becoming obsolete. 2. Biology Gradually disappearing; imperfectly or only slightly developed. of existing products, the resolution of existing and potential future patent issues, additional competition, changes in economic conditions, and other risks described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and subsequent reports on Form 10-Q Form 10-Q See 10-Q. . All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any undertaking to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion